Abstract

Introduction
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders of haematopoietic stem cells, characterised by ineffective haematopoiesis leading to peripheral cytopenias and hypercellular bone marrow, with increased propensity to progression to acute myeloid leukaemia. Anaemia is the most common symptom: it may precipitate symptoms in patients with cardiac disorders, thus affecting the patients' outcome. [...]

Downloads

Authors

Claudio Cerchione - Haematology Division, "Federico II" University Hospital, Naples, Italy

Giuseppe Cerciello - Haematology Division, "Federico II" University Hospital, Naples, Italy

Simona Avilia - Haematology Division, "Federico II" University Hospital, Naples, Italy

Roberta Della Pepa - Haematology Division, "Federico II" University Hospital, Naples, Italy

Novella Pugliese - Haematology Division, "Federico II" University Hospital, Naples, Italy

Marco Picardi - Haematology Division, "Federico II" University Hospital, Naples, Italy

Lucio Catalano - Haematology Division, "Federico II" University Hospital, Naples, Italy

Fabrizio Pane - Haematology Division, "Federico II" University Hospital, Naples, Italy

  • Abstract viewed - 2 times
  • PDF downloaded - 0 times